MétaCan
Menu
Back to cohort
Record W2595666038 · doi:10.18632/oncotarget.16376

Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway

2017· article· en· W2595666038 on OpenAlexfundno aff
Koji Ando, Ankur K. Shah, Vibhu Sachdev, Benjamin P. Kleinstiver, Julian Taylor‐Parker, Moira M. Welch, Yiheng Hu, Ravi Salgia, Forest M. White, Jeffrey D. Parvin, Al Ozonoff, Lucia E. Rameh, J. Keith Joung, Ajit Bharti

Bibliographic record

VenueOncotarget · 2017
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicCancer therapeutics and mechanisms
Canadian institutionsnot available
FundersNational Cancer InstituteNational Institute of General Medical SciencesNatural Sciences and Engineering Research Council of CanadaNational Institutes of HealthUehara Memorial Foundation
KeywordsCamptothecinUbiquitinProteasomeTopoisomeraseKu80BiologySerineCell biologyDNAChemistryBiochemistryPhosphorylationDNA-binding proteinTranscription factorGene

Abstract

fetched live from OpenAlex

// Koji Ando 1,* , Ankur K. Shah 1,* , Vibhu Sachdev 1 , Benjamin P. Kleinstiver 2,3 , Julian Taylor-Parker 1 , Moira M. Welch 2 , Yiheng Hu 4 , Ravi Salgia 5 , Forest M. White 6 , Jeffrey D. Parvin 4 , Al Ozonoff 7 , Lucia E. Rameh 8 , J. Keith Joung 2,3 and Ajit K. Bharti 1 1 Department of Medicine, Division of Hematology Oncology, Boston University School of Medicine, Boston, MA, USA 2 Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, MA, USA 3 Department of Pathology, Harvard Medical School, Boston, MA, USA 4 Department of Biomedical Informatics, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA 5 Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte , CA, USA 6 Department of Biological Engineering, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA 7 Center for Patient Safety and Quality Research, Boston Children’s Hospital, Boston, MA, USA 8 Department of Medicine, Obesity Research Center, Boston University School of Medicine, Boston, MA, USA * These authors have contributed equally to this work Correspondence to: Ajit K Bharti, email: // Keywords : topoisomerase I, BRCA1, DNAPK, PTEN, ubiquitin proteasome pathway Received : February 17, 2017 Accepted : March 03, 2017 Published : March 18, 2017 Abstract Proteasomal degradation of topoisomerase I (topoI) is one of the most remarkable cellular phenomena observed in response to camptothecin (CPT). Importantly, the rate of topoI degradation is linked to CPT resistance. Formation of the topoI-DNA-CPT cleavable complex inhibits DNA re-ligation resulting in DNA-double strand break (DSB). The degradation of topoI marks the first step in the ubiquitin proteasome pathway (UPP) dependent DNA damage response (DDR). Here, we show that the Ku70/Ku80 heterodimer binds with topoI, and that the DNA-dependent protein kinase (DNA-PKcs) phosphorylates topoI on serine 10 (topoI-pS10), which is subsequently ubiquitinated by BRCA1. A higher basal level of topoI-pS10 ensures rapid topoI degradation leading to CPT resistance. Importantly, PTEN regulates DNA-PKcs kinase activity in this pathway and PTEN deletion ensures DNA-PKcs dependent higher topoI-pS10, rapid topoI degradation and CPT resistance.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.207
Threshold uncertainty score0.384

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.011
GPT teacher head0.250
Teacher spread0.239 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations27
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueOncotargetSame topicCancer therapeutics and mechanismsFrench-language works237,207